Diagnosis and therapy of neutropenia in large granular lymphocyte leukemia

Current Opinion in Hematology

Volumn 16, Issue 1, 2009, Pages 27-34

  Mohan, Sanjay R ^a   Maciejewski, Jaroslaw P ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Cytotoxic T cell; Immunosuppression; Large granular lymphocyte leukemia; Neutropenia

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; CD57 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL PEPTIDASE IV; FAS LIGAND; METHOTREXATE; MONOCLONAL ANTIBODY; PERFORIN; PREDNISONE; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY;

ANTIGEN EXPRESSION; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CD8+ T LYMPHOCYTE; CELL CLONE; CELL POPULATION; CYTOPENIA; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LARGE GRANULAR LYMPHOCYTE; LOW DRUG DOSE; LYMPHOCYTE COUNT; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PATHOGENESIS; PRIORITY JOURNAL; RETICULOCYTE; REVIEW; T CELL LEUKEMIA;

ANEMIA; HUMANS; IMMUNOTHERAPY; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; NEUTROPENIA; PANCYTOPENIA;

EID: 58149125203     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32831c8407     Document Type: Review

References (89)

1. Au WY, Lam CC, Lie AK, et al. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol 2003; 120:626-630.
2. Mohty M, Faucher C, Gaugler B, et al. Large granular lymphocytes (LGL) following nonmyeloablative allogeneic bone marrow transplantation: a case report. Bone Marrow Transplant 2001 ; 28:1157-1160.
3. Mohty M, Faucher C, Vey N, et al. Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis 3. Leukemia 2002; 16:2129-2133.
4. Chang H, Kamel-Reid S, Hussain N, et al. T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders. Am J Clin Pathol 2005; 123:196-199.
5. Feher O, Barilla D, Locker J, et al. T-cell large granular lymphocytic leukemia following orthotopic liver transplantation. Am J Hematol 1995; 49:216-220.
6. Gentile TC, Hadlock KG, Uner AH, et al. Large granular lymphocyte leukaemia occurring after renal transplantation. Br J Haematol 1998; 101:507-512.
7. Viny AD, Lichtin A, Pohlman B, et al. Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia. Leuk Lymphoma 2008; 49:932-938.
8. Messmer BT, Albesiano E, Efremov DG, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004; 200:519-525.
9. Herve M, Xu K, Ng YS, et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 2005; 115:1636-1643.
10. Greer JP, Kinney MC, Loughran TP, Jr. T cell and NK cell lymphoproliferative disorders. Hematology (Am Soc Hematol Educ Program) 2001; 259-281.
11. Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia 1. Semin Hematol 2003; 40:185-195.
12. Mollet L, Fautrel B, Leblond V, et al. Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT. Leukemia 1999; 13:230-240.
13. Coakley G, Iqbal M, Brooks D, et al. CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. Arthritis Rheum 2000; 43:834-843.
14. Oshimi K, Shinkai Y, Okumura K, et al. Perforin gene expression in granular lymphocyte proliferative disorders. Blood 1990; 75:704-708.
15. Aprile JA, Russo M, Pepe MS, Loughran TP Jr. Activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes. Blood 1991; 78:1282-1285.
16. Lamy T, Liu JH, Landowski TH, et al. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998; 92:4771-4777.
17. Melenhorst JJ, Sorbara L, Kirby M, et al. Large granular lymphocyte leukaemia is characterized by a clonal T-cell receptor rearrangement in both memory and effector CD8(+) lymphocyte populations. Br J Haematol 2001; 112:189-194.
18. Nagata S. Apoptosis mediated by Fas and its related diseases. Nippon Ika Daigaku Zasshi 1997; 64:459-462.
19. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994; 179:873-879.
20. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154:3806-3813.
21. Suda T, Hashimoto H, Tanaka M, et al. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 1997; 186:2045-2050.
22. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999; 13:230-240.
23. Loughran TP Jr, Starkebaum G. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine (Baltimore) 1987; 66:397-405.
24. Rose MG, Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist 2004; 9:247-258.
25. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82:1-14.
26. Dhodapkar MV, Li CY, Lust JA, et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994; 84:1620-1627.
27. Kwong YL, Wong KF. Association of pure red cell aplasia with T large granular lymphocyte leukaemia. J Clin Pathol 1998; 51:672-675.
28. Go RS, Li CY, Tefferi A, Phyliky RL. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood 2001; 98:483-485.
29. Loughran TP Jr, Kadin ME, Starkebaum G, et al. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia 882. Ann Intern Med 1985; 102:169-175.
30. Akashi K, Shibuya T, Taniguchi S, et al. Multiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes. Br J Haematol 1999; 107:670-673.
31. Osuji N, Matutes E, Dearden C, Catovsky D. Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemia. Br J Haematol 2005;128:645-648.
32. Tefferi A, Li CY, Witzig TE, et al. Chronic natural killer cell lymphocytosis: a descriptive clinical study 10 2065. Blood 1994; 84:2721-2725.
33. Lamy T, Loughran TP. Large granular lymphocyte leukemia. Cancer Control 1998; 5:25-33.
34. Molad Y, Okon E, Stark P, Prokocimer M. Sjogren's syndrome associated T cell large granular lymphocyte leukemia: a possible common etiopathogenesis. J Rheumatol 2001; 28:2551-2552.
35. Marlton P, Taylor K, Elliott S, McCormack J. Monoclonal large granular lymphocyte proliferation in SLE with HTLV-I seroreactivity. Aust N Z J Med 1992; 22:54-55.
36. Lima M, Almeida J, Santos AH, et al. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol 2001; 159:1861-1868.
37. Charlanne H, Lambert M, Hachulla E, et al. Large granular lymphocyte leukaemia associated with systemic sclerosis. Rheumatology (Oxford) 2004; 43:1197-1198.
38. Valmori D, Ayyoub M, Hesdorffer CS, et al. A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3+ LGL-leukemia. Blood 2003; 101:4643-4644.
39. Kondo H, Watanabe J, Iwasaki H. T-large granular lymphocyte leukemia accompanied by an increase of natural killer cells (CD3-) and associated with ulcerative colitis and autoimmune hepatitis. Leuk Lymphoma 2001; 41:207-212.
40. Kaplanski G, Seidel-Farnarier C, Durand JM, et al. 'NK-like' T cytotoxicity against B lymphocytes in a hypogammaglobulinemic patient. Immunol Invest 1992; 21:601-612.
41. Starkebaum G, Loughran TP Jr, Gaur LK, et al. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1997; 40:624-626.
42. Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology (Am Soc Hematol Educ Program) 2004; 63-79.
43. Bowman SJ, Bhavnani M, Geddes GC, et al. Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Clin Exp Immunol 1995; 101:18-24.
44. Bowman SJ, Hall MA, Panayi GS, Lanchbury JS. T cell receptor alpha-chain and beta-chain junctional region homology in clonal CD3+, CD8+ T lymphocyte expansions in Felty's syndrome. Arthritis Rheum 1997; 40:615-623.
45. Handgretinger R, Geiselhart A, Moris A, et al. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med 1999; 340:278-284.
46. Fogarty PF, Stetler-Stevenson M, Pereira A, Dunbar CE. Large granular lymphocytic proliferation-associated cyclic thrombocytopenia. Am J Hematol 2005; 79:334-336.
47. Callan MF, Steven N, Krausa P, et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 1996; 2:906-911.
48. Pantaleo G, Demarest JF, Soudeyns H, et al. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994; 370:463-467.
49. Mongkolsapaya J, Jaye A, Callan MF, et al. Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol 1999; 73:67-71.
50. Kronenberg A, Seebach JD, Bossart W, Weber R. Polyclonal proliferation of large granular lymphocytes during cytomegalovirus primary infection in a human immunodeficiency virus-infected patient receiving antiretroviral therapy. Clin Infect Dis 2001; 33:E34-E36.
51. Risitano AM, Maciejewski JP, Muranski P, et al. Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients. Leukemia 2005; 19:217-222.
52. Karadimitris A, Li K, Notaro R, et al. Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH. Br J Haematol 2001; 115:1010-1014.
53. Go RS, Tefferi A, Li CY, et al. Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia 1. Blood 2000; 96:3644-3646.
54. Saunthararajah Y, Molldrem JL, Rivera M, et al. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001; 112:195-200.
55. Wlodarski MW, Gondek LP, Nearman ZP, et al. Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome. Blood 2006; 108:2632-2641.
56. Papadaki T, Stamatopoulos K, Kosmas C, et al. Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: report of eight cases. Leukemia 2002; 16:2167-2169.
57. Lesesve JF, Feugier P, Lamy T, et al. Association of B-chronic lymphocytic leukaemia and T-large granular lymphocyte leukaemia. Clin Lab Haematol 2000; 22:121-122.
58. Kingreen D, Dalal BI, Heyman M, et al. Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease. Am J Hematol 1995; 50:234-236.
59. Tanaka Y, Matsui K, Yamashita K, et al. T-gamma delta large granular lymphocyte leukemia preceded by pure red cell aplasia and complicated with hemophagocytic syndrome caused by Epstein-Barr virus infection 77. Intern Med 2006; 45:631-635.
60. Wlodarski MW, Nearman Z, Jiang Y, et al. Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia. Exp Hematol 2008; 36:293-300.
61. Liu JH, Wei S, Lamy T, et al. Chronic neutropenia mediated by fas ligand. Blood 2000; 95:3219-3222.
62. Wlodarski MW, O'Keefe C, Howe EC, et al. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 2005; 106:2769-2780.
63. Semenzato G, Zambello R, Starkebaum G, et al. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis 13. Blood 1997;89:256-260.
64. Melenhorst JJ, Eniafe R, Follmann D, et al. T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57. Hematol J 2003; 4:18-25.
65. Herling M, Khoury JD, Washington LT, et al. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 2004; 104:328-335.
66. Morice WG, Kurtin PJ, Leibson PJ, et al. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia 1. Br J Haematol 2003; 120:1026-1036.
67. Dang NH, Aytac U, Sato K, et al. T-large granular lymphocyte lymphoproli-ferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition. Br J Haematol 2003; 121:857-865.
68. Lundell R, Härtung L, Hill S, et al. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol 2005; 124:937-946.
69. Bigouret V, Hoffmann T, Arlettaz L, et al. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 2003; 101:3198-3204.
70. Hoffmann JJ, Breed WP. Two patients with chronic lymphocytosis of large granular lymphocytes; benign or premalignant? Ned Tijdschr Geneeskd 2000; 144:1323-1327.
71. Ryan DK, Alexander HD, Morris TC. Routine diagnosis of large granular lymphocytic leukaemia by Southern blot and polymerase chain reaction analysis of clonal T cell receptor gene rearrangement. Mol Pathol 1997; 50:77-81.
72. Berliner N, Duby AD, Linch DC, et al. T cell receptor gene rearrangements define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia. Blood 1986; 67:914-918.
73. Alekshun TJ, Tao J, Sokol L. Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature. Am J Hematol 2007; 82:481-485.
74. Fischer L, Hummel M, Burmeister T, et al. Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL). Hematol Oncol 2006; 24:78-85.
75. Gentile TC, Wener MH, Starkebaum G, Loughran TP Jr. Humoral immune abnormalities in T-cell large granular lymphocyte leukemia. Leuk Lymphoma 1996; 23:365-370.
76. Platanias L, Raefsky E, Young N. Neutropenia associated with large granular lymphocytes responsive to corticosteroids in vitro and in vivo. Eur J Haematol 1987; 38:89-94.
77. Thomssen C, Nissen C, Gratwohl A, et al. Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF). Br J Haematol 1989; 71:157-158.
78. Lang DF, Rosenfeld CS, Diamond HS, et al. Successful treatment of T-gamma lymphoproliferative disease with human-recombinant granulocyte colony stimulating factor. Am J Hematol 1992; 40:66-68.
79. Mulder AB, de Wolf JT, Smit JW, et al. Correction of neutropenia by GM-CSF in patients with a large granular lymphocyte proliferation. Ann Hematol 1992; 65:91-95.
80. Genvresse I, Spath-Schwalbe E, Lukowsky A, Possinger K. Delayed response to granulocyte colony-stimulating factor (G-CSF) in a case of severe neutropenia associated with large granular lymphocyte (LGL) leukemia. Eur J Haematol 1998; 60:133-134.
81. Sood R, Stewart CC, Aplan PD, et al. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998; 91:3372-3378.
82. Osuji N, Matutes E, Tjonnfjord G, et al. T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature. Cancer 2006; 107:570-578.
83. Loughran TP Jr, Kidd PG, Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994; 84:2164-2170.
84. Osuji N, Del GI, Matutes E, et al. CD52 expression in T-cell large granular lymphocyte leukemia - implications for treatment with alemtuzumab. Leuk Lymphoma 2005; 46:723-727.
85. Bargetzi MJ, Wortelboer M, Pabst T, et al. Severe neutropenia in T-large granular lymphocyte leukemia corrected by intensive immunosuppression. Ann Hematol 1996; 73:149-151.
86. La NG, Littera R, Cocco E, et al. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. Ann Hematol 2004; 83:403-405.
87. Ebihara Y, Manabe A, Tanaka R, et al. Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation. Bone Marrow Transplant 2003; 31:1169-1171.
88. Subbiah V, Viny AD, Rosenblatt S, et al. Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia. Exp Hematol 2008; 36:1078-1083. The above study describes potential role for splenectomy for those with refractory cytopenias.
89. Gentile TC, Loughran TP Jr. Resolution of autoimmune hemolytic anemia following splenectomy in CD3+ large granular lymphocyte leukemia. Leuk Lymphoma 1996; 23:405-408.